Abstract

Background: Hypertension and dyslipidemias are major risk factors for Coronary artery disease. It is well known that diabetes mellitus associated with dyslipidemias. But hypertension associated with abnormal lipid profile Also can occur. Various studies have shown that lipid levels are abnormally high in Hypertensive patients compared to control group. It appears that Dyslipidemias and hypertension may also have synergistic effect on atherosclerosis.

Aim and Objective: (1) To study the lipid values in hypertensive individuals. (2) Comparison of lipid values between smokers and non-smokers with hypertension. (3) Comparison of lipid values between obese and non-obese patients with hypertension. (4) Age wise distribution of hyperlipidemia.

Material and Methods: This prospective randomized clinical study entitled “A Study on Lipid Profile in Hypertensive Patients” A crossectional study was conducted after clearance from Board of Studies and Ethical committee in the Department of General Medicine at Rajshree medical and research institute and hospital during the period 2021-2022. The total sample size was determined to be 157 patients.

Results: Among study population, majority belonged to 40-50 years age group (52.9%) followed by 51-60 years (31.2%) and above 60 years (15.9%). The risk factors reported were Obesity (52.2%), Smoking (66.9%) and Alcohol (44.6%). Among the hypertensive patients Raised Total Cholesterol, LDL and Triglycerides was reported as 61.8%, 49.0% and 65.6% respectively. Low HDL was reported among 58.6% subjects. There was a significantly positive correlation of age with Total Cholesterol, LDL, and Triglycerides (61.8%, 49%, and 65% respectively). Low HDL was reported among 58.6% subjects. There was a significantly negative correlation of age with HDL. Raised Total Cholesterol, LDL and Triglycerides was significantly more among smokers (73.1%, 59.6% and 75.0% respectively) compared to non-smokers (56.2%, 43.8% and 61.0% Raised Total Cholesterol, LDL and Triglycerides was significantly more among obese people (96.3%, 92.7%, and 92.7% respectively) low HDL (100%) was significantly more among obese people.

Conclusion: In the research area hypertension individuals had a significant frequency of abnormal lipid profiles and poorly managed blood pressure, according to the study findings.

• 1.   Hernandez-Vila E. A review of the JNC 8 blood pressure guideline. Tex Heart Inst J. 2015;42(3):226-8.
• 2.   Flack JM, Adekola B. Blood pressure and the new ACC/AHA hypertension guidelines. Trends Cardiovasc Med. 2020;30(3):160-4.
• 3.   Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. Guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;73(24):e285-350.
• 4.   Agarwal P, Pandey S. A study on the lipid profile of hypertensive patients. Int J Med Biomed Stud. 2019;3(4).
• 5.   Han SH, Quon MJ, Koh KK. Reciprocal relationships between abnormal metabolic parameters and endothelial dysfunction. Curr Opin Lipidol. 2007;18:58-65.
• 6.   Sacks FM, Campos H. Clinical review 163: cardiovascular endocrinology: low-density lipoprotein size and cardiovascular disease: a reappraisal. J Clin Endocrinol Metab. 2003;88:4525-32.
• 7.   Urbina EM, Srinivasan SR, Kieltyka RL, et al. Correlates of carotid artery stiffness in young adults: the Bogalusa Heart Study. Atherosclerosis. 2004;176:157-64.
• 8.   Sesso HD, Buring JE, Rifai N, Blake GJ, Gaziano JM, Ridker PM. C-reactive protein and the risk of developing hypertension. JAMA. 2003;290:2945-51.
• 9.   Chruściel P, Stemplewska P, Stemplewski A, Wattad M, Bielecka-Dąbrowa A, Maciejewski M, et al. Associations between the lipid profile and the development of hypertension in young individuals – the preliminary study. Arch Med Sci. 2022;18(1):25-35.
• 10.   Yin R, Chen Y, Pan S, He F, Liu T, Yang D, et al. Comparison of lipid levels, hyperlipidemia prevalence and its risk factors between Guangxi Hei Yi Zhuang and Han populations. Arch Med Res. 2006;37(6):787-93.
• 11.   Pyadala N, Bobbiti RR, Borugadda R, Bitinti S, Maity SN, Mallepaddi PC, et al. Assessment of lipid profile among hypertensive patients attending to rural teaching hospital, Sangareddy. Int J Med Sci Public Health. 2017;6(1):71-6.
• 12.   Kannel WB. Fifty years of Framingham Study contributions to understanding hypertension. J Hum Hypertens. 2000;14(2):83–90.
• 13.   Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143–421.
• 14.   Tunstall-Pedoe H. What was preventing coronary heart disease (CHD) prevention and why its time has now come. In: Wood D, McLeod A, Davis M, Miles A, editors. Effective Secondary Prevention and Cardiac Rehabilitation. London: Aesculapius Press; 2002. p. 3–13.
• 15.   Eaton CB, Feldman HA, Assaf AR, et al. Prevalence of hypertension, dyslipidemia, and dyslipidemic hypertension. J Fam Pract. 1994;38(1):17–23.
• 16.   Schröder H, Schmelz E, Marrugat J. Relationship between diet and blood pressure in a representative Mediterranean population. Eur J Nutr. 2002;41(4):161–7.
• 17.   Xu C, Yang X, Zu S, Han S, Zhang Z, Zhu G. Association between serum lipids, blood pressure, and simple anthropometric measures in an adult Chinese population. Arch Med Res. 2008;39(6):610–7.
• 18.   Cappuccio FP, Micah FB, Emmett L. Prevalence, detection, management and control of hypertension in Ashanti, West Africa. Hypertension. 2004;43:1017-22.
• 19.   Gupta R. Trends in hypertension epidemiology in India. J Hum Hypertens. 2004;18:73-8.
• 20.   Butola KS, Singh B, Gupta D, Nath B. Assessment of serum lipid profile among hypertensive patients in Uttarakhand. Santosh Univ J Health Sci. 2016;2(2):122-4.
• 21.   Mahapatro AK, Chandrika S, Chepuru R. A study of lipid profile abnormalities among patients with essential hypertension attending tertiary care centre. Int J Contemp Med Res. 2020;7(1):A1-4.
• 22.   Gebrie A, Gnanasekaran N, Menon M, Sisay M, Zegeye A. Evaluation of lipid profiles and hematological parameters in hypertensive patients: laboratory-based cross-sectional study. SAGE Open Med. 2018;6:1-11.
• 23.   Michael OA, Bimbola FM, Rotimi O. The relationship between measures of obesity and atherogenic lipids among Nigerians with hypertension. Malawi Med J. 2019;31(3):193-7.
• 24.   Bindu CB, Lokesh HC. Study of lipid profile in newly detected adult hypertensive patients. Acad J Med. 2019;2(2):129-31.

Data Sharing Statement

Funding